EAACI Congress 2025
BackOAS04 - Drug Allergy: from bench to bedside
Friday 13 Jun, 15:00 PM -
16:30 PM Glasgow, United Kingdom
Carron 2
Oral Abstract Sessions
15:00
Evaluation of MRGPRX2-mediated mast cell activation in immediate hypersensitivity reactions to neuromuscular blocking agents
15:12
Unlocking the Potential of Cytokines for Endotyping Immediate Hypersensitivity Reactions Induced by Chemotherapeutic and Biological Agents
15:24
Efficacy and Safety of Chemotherapeutic Drug Desensitization in Children
15:36
The value of skin testing with TNF-inhibitors in patients with local and systemic hypersensitivity reactions
15:48
Meloxicam as a Safe Bet: Rethinking the Approach to NSAID Hypersensitivity Alternative Drugs
16:00
Efficacy of aspirin therapy after desensitization on CRSwNP patients with N-ERD - a RDBCT study
16:12
Low-dose acetylsalicylic acid therapy after desensitization is safe for pregnant women with NSAID-induced urticaria/angioedema and NASID-exacerbated cutaneous disease
